![Takashi Kamimura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 669 248 $ al 31/05/2026
Takashi Kamimura worked as Director & Manager-Drug Discovery at Teijin Pharma Ltd. from 2009 to 2013.
Dr. Kamimura also worked as Director at Veritas In Silico Inc. from 2017 to 2019.
Former jobs include Director & Manager-Drug Discovery at Teijin Pharma Ltd. and Director at Veritas In Silico Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VERITAS IN SILICO INC. 3,95 % | 20/06/2025 | 256.100 ( 3,95 % ) | 669 248 $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Teijin Pharma Ltd.
 Teijin Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products & medical devices | Director/Miembro de la Junta | 31/03/2013 |
| VERITAS IN SILICO INC. | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 2 |
|---|---|
Teijin Pharma Ltd.
Teijin Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products & medical devices | Health Technology |
Veritas In Silico Inc.
 Veritas In Silico Inc. BiotechnologyHealth Technology Develops drugs against structural motifs on mRNA | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
